$PRTA

Smith Brandon S. sold (to issuer) $668K of PRTA

Smith Brandon S. (Chief Operating Officer) sold (to issuer) 78,000 shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $8.56 ($0.67M total) on 2026-07-28.

Original reporting
SEC EDGAR · Smith Brandon S.
Published Jul 31, 2026, 12:33 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 1:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PRTA
Neutral
medium confidence
Mentioned
$PRTA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PRTANeutralLow
01

Why it matters

The newest information is the specific insider sale: 78,000 shares at $8.56/share on 2026-07-28, with holdings after transaction of 52,000 shares.

02

Market read

Traders may monitor insider activity, but this filing alone does not provide a catalyst for repricing PRTA based on fundamentals.

03

What to watch

Sales to the issuer can occur via structured arrangements (e.g., tax or liquidity mechanics) and may not reflect a view on valuation or prospects.

Relevance 5/10Novelty 3/10Timing: filed 2026-07-30 for a 2026-07-28 sale

Background

The article is a SEC Form 4 insider transaction disclosure for Prothena Corp Public Ltd Co (PRTA).

Company-level read

Ticker impact

$PRTANeutralMedium confidence
Context

Prothena COO Brandon Smith sold 78,000 shares to the issuer at $8.56/share for $667,680, per a new Form 4 filing.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing provides transaction details (size, price, post-sale holdings) but no accompanying guidance, operational change, or regulatory/legal development.

Market effects

Minimal; routine insider transaction with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could be interpreted as discretionary selling, which some traders may read as caution.

Key entities

  • PROTHENA CORP PUBLIC LTD CO

    Subject of the Form 4 insider transaction disclosure.

  • Brandon S. Smith

    Chief Operating Officer who sold shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PRTAMed

PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus

Prothena (PRTA) reported Q2 2026 adjusted loss per share of 32 cents, narrower than the Zacks estimate of a 39-cent loss. Revenues were $1.01 million versus $4.4 million a year earlier, mainly collaboration revenue from Bristol Myers Squibb (BMY) for PRX019. Prothena had $330.3 million cash, no debt, and reaffirmed 2026 net cash use guidance of $18-$23 million.

$PRTAMed

Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

PROTHENA CORP PUBLIC LTD CO (PRTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PRESS RELEASE Prothena Reports Second Quarter 2026 Financial Results an d Business Highlights • Net cash used in operating and investing activities was $25.7 million in the second quarter, and net cash provided by operating and investing activities was $3.2 million f

$COURMedAI 8/10

Pale Fire Capital SE (Senkypl Dusan, Barta Jan) purchased $11.4M of COUR (indirect holdings)

Pale Fire Capital SE purchased 2,332,742 indirectly-held shares of Coursera, Inc. (COUR) at an average of $4.87 ($4.61–$5.06, $11.36M total) across 2 trades over 2026-09-25 to 2026-09-29. Filed jointly with Pale Fire Capital SICAV a.s. (10% owner), Pale Fire Capital investicni spolecnost a.s. (10% owner), Senkypl Dusan (10% owner) and Barta Jan (10% owner).